Gene Therapy Wins FDA Approval for Life-Threatening Immunodeficiency

(MedPage Today) -- The FDA on Tuesday approved etuvetidigene autotemcel (Waskyra) as the first cell-based gene therapy for patients 6 months and older with Wiskott-Aldrich syndrome, a rare primary immunodeficiency.
The life-threatening genetic...